From model to medicine: Closing the preclinical to clinical gap with an integrated, data-driven engine

Richard Klinghoffer, SVP and Head of Systems Biology at Tempus, discusses how preclinical models can be disconnected from real patient biology, contributing to challenges in oncology drug development.